MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No

被引：1
|
作者：
Ebers, George C. [1 ]
机构：
[1] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 03期
关键词：
LONG-TERM DISABILITY; INTERFERON BETA-1B; RELAPSES;
D O I：
10.1177/1352458513518264
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：282 / 283
页数：2
相关论文
共 50 条
  • [31] Evidence Supporting the Use of MRI as a Surrogate for Clinical Endpoints in Randomized Controlled Trials for Pediatric Multiple Sclerosis
    Brown, Robert
    O'Mahony, Julia
    Yeh, E. Ann
    Marrie, Ruth-Ann
    Bar-Or, Amit
    Banwell, Brenda
    Arnold, Douglas
    NEUROLOGY, 2017, 88
  • [32] Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
    Filippi, Massimo
    Preziosa, Paolo
    Rocca, Maria A.
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (03) : 290 - 299
  • [33] OUTCOME MEASURES FOR CLINICAL-TRIALS IN MULTIPLE-SCLEROSIS - REPLY
    MCFARLAND, HF
    ANNALS OF NEUROLOGY, 1992, 31 (01) : 116 - 117
  • [34] Appropriate design and outcome measures in multiple sclerosis clinical trials - Response
    Khan, OA
    Tselis, AC
    Kamholz, JA
    Garbern, JY
    Lewis, RA
    Lisak, RP
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (05) : 505 - 506
  • [35] Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics
    DeRen Huang
    Neuroscience Bulletin, 2015, 31 (06) : 745 - 754
  • [36] Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Uitdehaag, Bernard
    Cutter, Gary
    NEUROLOGY, 2021, 96 (01) : E111 - E120
  • [37] Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics
    Huang, DeRen
    NEUROSCIENCE BULLETIN, 2015, 31 (06) : 745 - 754
  • [38] Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics
    DeRen Huang
    Neuroscience Bulletin, 2015, 31 : 745 - 754
  • [39] Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis
    Cawley, Niamh
    Tur, Carmen
    Prados, Ferran
    Plantone, Domenico
    Kearney, Hugh
    Abdel-Aziz, Khaled
    Ourselin, Sebastian
    Wheeler-Kingshott, Claudia A. M. Gandini
    Miller, David H.
    Thompson, Alan J.
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (07) : 932 - 941
  • [40] PATIENT-REPORTED OUTCOME MEASURES FOR MULTIPLE SCLEROSIS PHASE IV CLINICAL TRIALS: A SYSTEMATIC REVIEW
    Ting, J.
    Zhong, L.
    Petrillo, J.
    Niu, C.
    Lee, A.
    Sarda, S.
    VALUE IN HEALTH, 2015, 18 (03) : A286 - A286
12345